- Q4 2023 Amicus Therapeutics Inc Earnings Call TranscriptFeb 28, 2024$12.95 (-6.50%)Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Amicus Therapeutics Inc at UBS BioPharma Conference TranscriptNov 09, 2023
- Q3 2023 Amicus Therapeutics Inc Earnings Call TranscriptNov 08, 2023$11.36 (-2.99%)Earnings
- Amicus Therapeutics Inc to Discuss the FDA Approval Call TranscriptSep 28, 2023
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Amicus Therapeutics Inc Earnings Call TranscriptAug 08, 2023$13.86 (+10.53%)Earnings
- Amicus Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Amicus Therapeutics Inc Earnings Call TranscriptMay 10, 2023$11.58 (-5.00%)Earnings
- Q4 2022 Amicus Therapeutics Inc Earnings Call TranscriptMar 01, 2023$13.54 (+2.65%)Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q3 2022 Amicus Therapeutics Inc Earnings Call TranscriptNov 07, 2022$10.31 (+1.98%)Earnings
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Amicus Therapeutics Inc Earnings Call TranscriptAug 04, 2022$10.94 (+5.50%)Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Amicus Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Amicus Therapeutics Inc Earnings Call TranscriptMay 09, 2022$6.23 (-0.64%)Earnings
- Q4 2021 Amicus Therapeutics Inc Earnings Call TranscriptFeb 24, 2022$8.48 (+2.79%)Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Amicus Therapeutics Inc Earnings Call TranscriptNov 09, 2021$11.32 (-5.11%)Earnings
- Amicus Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Amicus Therapeutics Inc and ARYA Sciences Acquisition IV Corp to Announce Formation of a Next-Generation Genetic Medicine Company Call TranscriptSep 29, 2021
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Amicus Therapeutics Inc Earnings Call TranscriptAug 05, 2021$10.06 (+3.93%)Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Amicus Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 24, 2021
- Amicus Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Amicus Therapeutics Inc Earnings Call TranscriptMay 10, 2021$9.39 (-3.69%)Earnings
- Q4 2020 Amicus Therapeutics Inc Earnings Call TranscriptMar 01, 2021$11.79 (-3.99%)Earnings
- Amicus Therapeutics Inc to Discuss the Topline PROPEL Results - Conference Call TranscriptFeb 11, 2021
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Amicus Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Amicus Therapeutics Inc Earnings Call TranscriptNov 05, 2020$21.34 (+2.89%)Earnings
- Amicus Therapeutics Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- Amicus Therapeutics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 Amicus Therapeutics Inc Earnings Call TranscriptAug 10, 2020$15.23 (-1.17%)Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Q1 2020 Amicus Therapeutics Inc Earnings Call TranscriptMay 07, 2020$11.62 (-2.02%)Earnings
- Q4 2019 Amicus Therapeutics Inc Earnings Call TranscriptMar 02, 2020$9.32 (-2.36%)Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 Amicus Therapeutics Inc Earnings Call TranscriptNov 11, 2019$9.28 (+3.80%)Earnings
- Amicus Therapeutics Inc Analyst Day TranscriptOct 10, 2019
- Q2 2019 Amicus Therapeutics Inc Earnings Call TranscriptAug 08, 2019$11.39 (-3.72%)Earnings
- Amicus Therapeutics Inc Presents Positive Interim Clinical Data for CLN6 Batten Disease Conference Call TranscriptAug 01, 2019
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Amicus Therapeutics Inc and the University of Pennsylvania Expansion of Gene Therapy Collaboration - Call TranscriptMay 29, 2019
- Amicus Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Amicus Therapeutics Inc Earnings Call TranscriptMay 08, 2019$13.11 (-4.10%)Earnings
- Amicus Therapeutics Inc to Discuss the Preclinical Data Presented at ASGCT - Call TranscriptApr 30, 2019
- Amicus Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Amicus Therapeutics Inc Earnings Call TranscriptFeb 28, 2019$12.1 (-2.65%)Earnings
- Amicus Therapeutics Inc to Discuss the Clinical Pompe Disease Data and Preclinical Batten Disease Data Presented at the WORLDSymposium TranscriptFeb 07, 2019
Amicus Therapeutics Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
(technical difficulty)
The development for Pompe disease, and that's slated to read out early next year. And then we have a broad gene therapy pipeline, importantly, 2 clinical-stage programs in CLN6 and CLN3 Batten disease and a number of additional programs in preclinical development. And in such a strange year, it has been this year, it's been a great year so far for Amicus, even in the face of COVID and the global pandemic. Galafold, as I mentioned, is on track from a revenue perspective. Our Pompe program, we've been able to maintain the integrity of that study and really looking forward to seeing that readout and continue to progress the other programs as well.
So for the first half of the year, we've seen strong performance in our business and across our business and look forward to continued performance in the months ahead.
Questions & Answers
Okay. Great. So let's dive into some detailed
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)